These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35240818)

  • 1. Identification of SSBP1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches.
    Huang J; Xie ZF
    Math Biosci Eng; 2022 Jan; 19(3):3022-3035. PubMed ID: 35240818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
    Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
    BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of clinical value and potential mechanism of MTFR2 in lung adenocarcinoma via bioinformatics.
    Chen C; Tang Y; Qu WD; Han X; Zuo JB; Cai QY; Xu G; Song YX; Ke XX
    BMC Cancer; 2021 May; 21(1):619. PubMed ID: 34039308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Expression of
    Deng H; Huang Y; Wang L; Chen M
    Biomed Res Int; 2020; 2020():2071593. PubMed ID: 33134373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLC2A5 Correlated with Immune Infiltration: A Candidate Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma.
    Luo L; Su J; Zheng Y; Huang F; Huang R; Luo H
    J Immunol Res; 2021; 2021():9938397. PubMed ID: 34604392
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Tan Z; Chen M; Wang Y; Peng F; Zhu X; Li X; Zhang L; Li Y; Liu Y
    Biomark Med; 2022 Feb; 16(2):83-100. PubMed ID: 34882011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) correlates with poor prognosis and immune infiltration in lung adenocarcinoma.
    Zhuo X; Chen L; Lai Z; Liu J; Li S; Hu A; Lin Y
    Bioengineered; 2021 Dec; 12(1):8336-8346. PubMed ID: 34592886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma.
    Chen A; Ding S; Shen X; Lin X
    Comput Math Methods Med; 2021; 2021():9932088. PubMed ID: 34367321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EZH2 as a prognostic-related biomarker in lung adenocarcinoma correlating with cell cycle and immune infiltrates.
    Fan K; Zhang BH; Han D; Sun YC
    BMC Bioinformatics; 2023 Apr; 24(1):149. PubMed ID: 37069494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
    Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ
    Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085
    [No Abstract]   [Full Text] [Related]  

  • 11. Comprehensive Analysis of YTH Domain Family in Lung Adenocarcinoma: Expression Profile, Association with Prognostic Value, and Immune Infiltration.
    Hu K; Yao L; Yan Y; Zhou L; Li J
    Dis Markers; 2021; 2021():2789481. PubMed ID: 34497675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of potential diagnostic and prognostic biomarkers for LUAD based on TCGA and GEO databases.
    Zheng Q; Min S; Zhou Q
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34017995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Junctional Adhesion Molecule-Like Protein (JAML) Is Correlated with Prognosis and Immune Infiltrates in Lung Adenocarcinoma.
    Fang L; Yu W; Yu G; Zhong F; Ye B
    Med Sci Monit; 2022 Jan; 28():e933503. PubMed ID: 35034089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PHD3 as a Prognosis Marker and its Relationship with Immune Infiltration in Lung Adenocarcinoma.
    Wang L; Zhong Y; Wang G; An H; Gao Q; Ye Y
    Comb Chem High Throughput Screen; 2022; 25(13):2255-2263. PubMed ID: 35088661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
    Wu P; Zheng Y; Wang Y; Wang Y; Liang N
    J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated analyzes identify CCT3 as a modulator to shape immunosuppressive tumor microenvironment in lung adenocarcinoma.
    Huang J; Hu B; Yang Y; Liu H; Fan X; Zhou J; Chen L
    BMC Cancer; 2023 Mar; 23(1):241. PubMed ID: 36918801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An integrated analysis of prognostic and immune infiltrates for hub genes as potential survival indicators in patients with lung adenocarcinoma.
    Xu Z; Wang S; Ren Z; Gao X; Xu L; Zhang S; Ren B
    World J Surg Oncol; 2022 Mar; 20(1):99. PubMed ID: 35354488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent Prognostic Potential of GNPNAT1 in Lung Adenocarcinoma.
    Zheng X; Li Y; Ma C; Zhang J; Zhang Y; Fu Z; Luo H
    Biomed Res Int; 2020; 2020():8851437. PubMed ID: 33178836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC.
    Fu L; Wang H; Wei D; Wang B; Zhang C; Zhu T; Ma Z; Li Z; Wu Y; Yu G
    PLoS One; 2020; 15(5):e0233283. PubMed ID: 32437446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H2A Histone Family Member Z (H2AFZ) Serves as a Prognostic Biomarker in Lung Adenocarcinoma: Bioinformatic Analysis and Experimental Validation.
    Li Z; Hu M; Qiu J; Feng J; Zhang R; Wu H; Hu G; Ren J
    Med Sci Monit; 2022 Jan; 28():e933447. PubMed ID: 35027526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.